If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLTG.L Regulatory News (BLTG)

  • There is currently no data for BLTG

Board Appointment

1 Dec 2014 07:00

RNS Number : 3913Y
Regenersis PLC
01 December 2014
 

1 December 2014

 

REGENERSIS PLC

("Regenersis")

 

BOARD APPOINTMENT

 

Regenersis plc (AIM: RGS), a strategic outsourcing partner to many of the world's leading consumer technology companies, is pleased to announce that Dr Frank Blin CBE has been appointed to the Board as a Non-Executive Director and Senior Independent Director with immediate effect. Frank has also been appointed Chairman of the Audit Committee and a member of the Remuneration Committee with immediate effect.

 

Frank, aged 60, enjoyed a long and successful career with PwC, becoming Head of UK Regions and a UK Management Board member before his retirement in 2012. He was awarded a CBE for his services to the Scottish financial sector in 2002 and was awarded an honorary Doctorate of Business Administration by the University of Strathclyde in 2010. In the last five years, Frank has held the following Directorships:

 

Current:

· DCM (Optical Holdings) Limited

· FRB (Consultancy) Limited

· London and Scottish Investments Limited

· Urica Limited

 

Past:

· Ainscough Crane Hire Limited (shadow)

· Carduus Limited

 

Frank is also a designated member of FRB Associates LLP. There is no further information required to be disclosed in accordance with Schedule 2, paragraph (g) of the AIM Rules.

 

Matthew Peacock, Chairman, said: "I am delighted to welcome Frank to the Board. He brings a wealth of transaction and board experience working with growth businesses. We look forward to his contribution and working with him."

 

Enquiries:

 

Regenersis Plc +44 (0) 20 3657 7000

Matthew Peacock, Executive Chairman

Jog Dhody, Chief Financial Officer

 

Panmure Gordon (UK) Limited (Nomad and Joint Broker) +44 (0) 20 7886 2500

Dominic Morley, Corporate Finance

Charles Leigh Pemberton, Corporate Broking

 

Cenkos Securities (Joint Broker) +44 (0) 20 7397 8900

Stephen Keys, Corporate Finance

 

Tavistock Communications +44 (0) 20 7920 3150

Catriona Valentine / Matt Ridsdale / Emma Blinkhorn

 

Regenersis provides a suite of product life cycle support services designed to help companies and their customers successfully deploy, protect, sustain, retire and re-use digital technology.

 

www.regenersis.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUWOBRSWAAUAA
Date   Source Headline
3rd Oct 20232:12 pmPRNForm 8.3 - Blancco Technology Group Plc
3rd Oct 20237:00 amRNSAcceptance Level Update
2nd Oct 20232:49 pmRNSForm 8.3 - BLANCCO TECHNOLOGY GROUP PLC
2nd Oct 202311:12 amRNSForm 8.3 - Blancco Technology Group PLC
2nd Oct 20237:00 amRNSACCEPTANCE LEVEL UPDATE
28th Sep 20232:07 pmRNSForm 8.3 - Blancco Technology Group plc
28th Sep 202311:52 amRNSForm 8.3 - Blancco Technology Group PLC
28th Sep 202310:22 amRNSForm 8.3 - Blancco Technology Group PLC
27th Sep 20232:03 pmRNSForm 8.3 - Blancco Technology Group PLC
27th Sep 20231:16 pmPRNForm 8.3 - Blancco Technology Group Plc
27th Sep 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
27th Sep 202311:40 amRNSForm 8.3 - Blancco Technology Group plc
27th Sep 202311:11 amRNSNotification of Major Holdings
27th Sep 20237:00 amRNSAcceptance Level Update
27th Sep 20237:00 amRNSForm 8.3 - Blancco Technology Group PLC
26th Sep 202311:16 amRNSForm 8.3 - Blancco Technology Group PLC
22nd Sep 20232:19 pmRNSForm 8.3 - Blancco Technology Group plc
22nd Sep 202311:44 amRNSForm 8.3 - Blancco Technology Group plc
20th Sep 20231:22 pmRNSForm 8.3 - Blancco Technology Group plc
20th Sep 202311:31 amRNSForm 8.3 - Blancco Technology Group PLC
20th Sep 20237:00 amRNSAcceptance Level Update
19th Sep 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
18th Sep 20232:19 pmRNSForm 8.3 - Blanco Technology Group
15th Sep 20232:10 pmPRNForm 8.3 - Blancco Technology Group Plc
15th Sep 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
15th Sep 202310:25 amGNWForm 8.3 - Blancco Technology Group Plc
14th Sep 20236:26 pmBUSForm 8.3 - Blancco Technology Group plc
14th Sep 20239:32 amGNWForm 8.3 - Blancco Technology Group Plc
13th Sep 20237:00 amRNSAcceptance Level Update
8th Sep 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
8th Sep 202311:24 amRNSForm 8.3 - Blancco Technology Group PLC
6th Sep 20237:00 amRNSAcceptance Level Update
5th Sep 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
4th Sep 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
1st Sep 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
1st Sep 202311:21 amRNSForm 8.3 - Blancco Technology Group PLC
1st Sep 20239:48 amRNSForm 8.3 - Blancco Technology Group PLC
31st Aug 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
31st Aug 20239:00 amBUSForm 8.3 - Blancco Technology Group PLC
30th Aug 20237:00 amRNSAcceptance Level Update
22nd Aug 202310:48 amRNSForm 8.3 - Blancco Technology Group PLC
18th Aug 202311:07 amGNWForm 8.3 - Blancco Technology Group Plc
16th Aug 202310:33 amRNSFORM 8 (OPD) - Blancco Technology Group plc
14th Aug 20237:00 amBUSForm 8.3 - Blancco Technology Group plc
11th Aug 202311:29 amBUSForm 8.3 - Blancco Technology Group Plc
9th Aug 20233:37 pmRNSForm 8.3 - Blancco Technology Group PLC
9th Aug 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
8th Aug 20234:59 pmRNSPublication and Posting of Offer Document
8th Aug 202312:00 pmRNSForm 8.5 (EPT/RI) - Blancco Technology Group plc
7th Aug 20239:34 amGNWForm 8.3 - Blancco Technology Group Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.